The Beginning of a New Era in RSV Control

Pediatrics. 2023 Nov 1;152(5):e2023063817. doi: 10.1542/peds.2023-063817.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents*
  • Humans
  • Palivizumab
  • Vaccines*

Substances

  • Palivizumab
  • Antiviral Agents
  • Vaccines